Drug discovery

Pharmaceutical companies need to replenish their portfolios. But are biologics the way to go? Part 2 of Nuala Moran's report from Düsseldorf.

Civo BioScreening is looking for strategic partnerships to help it take forward its novel polymer screening technology.

A Danish biopharmaceutical company and the University of Copenhagen, Denmark, have set up the MicroRNA Research Consortium, with funding from the Danish Advanced Technology Foundation.

A spin-out from Oxford University is looking to attract the attention of equity investors and pharmaceutical companies by focusing on the discovery and development of small molecules to treat cancer

A spin-out from Sheffield that uses stem cells to help with conventional drug discovery is looking for investment to continue pre-clinical research on therapeutic applications and business development activities.